Focus In The Biotech Sector Could Soon Turn To These Therapeutic Areas And Companies
While vaccine makers have gotten most of the attention in the biotech sector over the past year, the author of today’s article advises that other…
Biotech Investments
While Biotech Underperformed In The First Half Of 2021, These Names Stood Out With Solid Gains
While biotech stocks underperformed the broader market in the first half of the year, some names – particularly those focused on neurodegenerative diseases and cancer…
Ridding Cancer Patients Of “Undruggable Targets” Could Be A Boon For This Biotech Stock
What makes the biotech stock featured in today’s article a buy according to an analyst who recently initiated coverage of it? The potential for its…
A Sober Look At This Psychedelic Stock
Amid growing acceptance of the use of psychedelic drugs for treating mental disorders, the clinical-stage biotech company featured in today’s article, which has a pipeline…
Even SPAC Skeptics Are Intrigued By This One
While the contributors to today’s article are not necessarily fans of blank check special purpose acquisition companies (SPACs), they cannot help but be intrigued by…
Hijacking The Immune System Creates A Huge Opportunity For These Biotech Stocks
A huge opportunity exists for a group of biotech stocks seeking to “hijack the immune system” with bispecific antibodies. Just what are bispecific antibodies –…
3 Trends Shaping The Future Of The Biotech Industry – And 3 Biotech Stocks Well Positioned To Outperform
Assessing the current state of the biotech industry, the author of today’s article notes that “While the coronavirus treatments will take center stage in 2021,…
How Will The Election Results Affect Tech, Growth, Biotech And Healthcare – And Who Will Outperform?
While President Trump still refuses to concede and control of the Senate is still technically to be determined, a Biden presidency come January 20th appears…
A High Risk/High Reward Way To Play The Shift To Biotech Solutions
When it comes to treating diseases, the author of today’s article notes “It seems that there is a shift away from treating symptoms with chemical…
The Approval Of An Oregon Ballot Measure Could Make This Biotech Startup An Under-The-Radar Election Winner
Amid all the high drama surrounding last week’s elections, a smaller development could have big implications for one biotech startup. As today’s article explains, voters…